جست‌وجوی استاد و پژوهشگر

Jennifer A. Smithمشاهده پروفایل

دانشیار

• Genetic Epidemiology
• Epigenomics
• Aging
• +۴ مورد دیگر

Jennifer A. Smith, PhD, MPH is an Associate Professor of Epidemiology and Research Associate Professor of Survey Research at the University of Michigan School of Public Health . She also serves as Director of the Certificate in Public Health Genetics and is Assistant Director of the Cohort Development working group for U-M Precision Health and the Michigan Genomics Initiative. Education: PhD, Epidemiology, University of Michigan (2011) MA, Statistics, University of Michigan (2009) MPH, Health Management and Policy, University of Michigan (2005) BS, Biological Sciences, Cornell University (2001) Research Interests: Dr. Smith is a genetic epidemiologist whose work lies at the intersection of genomics, epigenomics, and social epidemiology . She investigates how genetic, epigenetic, and transcriptomic variation influence age-related chronic diseases such as cardiovascular disease, hypertension, dementia, and cognitive decline. A major focus is understanding how social, psychosocial, and neighborhood determinants interact with genetic risk to shape socioeconomic and racial/ethnic health disparities . Research Projects: Her work leverages large, multi-ethnic cohorts including the Health and Retirement Study (HRS), GENOA, SWAN, MESA, and LASI. She is a core faculty member of the Center for Social Epidemiology and Population Health (CSEPH) , and affiliated with MiCDA, the Center for Midlife Science, and the PNG Program . She also collaborates with leading consortia such as CHARGE and TOPMed. Selected Trends in Publications: Her recent work (2022–2025) emphasizes epigenetic mediation of social determinants on cardiovascular and cognitive health, polygenic risk scores across diverse ancestries , and multi-omics integration in aging and disease. These studies consistently highlight how social environments and genetic architecture jointly influence health outcomes across populations. Contact: Email: smjenn@umich.edu Office: 734-615-9455 Address: 2631 SPH I, 1415 Washington Heights, Ann Arbor, MI 48109

Waldemar Kolanusمشاهده پروفایل

استاد

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

Peter A. Jonesمشاهده پروفایل

استاد

• Epigenetics
• DNA methylation
• Cancer epigenetics
• +۷ مورد دیگر

Peter A. Jones is President and Chief Scientific Officer at the Van Andel Institute (VAI) in Grand Rapids, Michigan, where he leads the Department of Epigenetics. He previously served as Director of the USC Norris Comprehensive Cancer Center from 1993 to 2011 and has been a central figure in advancing epigenetics research, particularly in cancer. His laboratory investigates DNA methylation, chromatin dynamics, and epigenetic therapies. Research Interests: Dr. Jones's work centers on epigenetic mechanisms in cancer, including DNA methylation, histone modifications, nucleosome positioning, and the therapeutic potential of epigenetic drugs. His research has pioneered the use of DNA methylation inhibitors like 5-azacytidine and explored viral mimicry as a mechanism for immune activation in cancer. He also studies transposable elements and their role in gene regulation and immune response. Publication Trends: His recent publications (2021–2024) reveal a strong focus on the interplay between epigenetics and immunotherapy, particularly how DNA methyltransferase inhibitors (DNMTi) induce viral mimicry, enhance immune recognition, and improve responses to checkpoint blockade. Studies span hematological malignancies, solid tumors, and T cell biology, with frequent collaboration with Stephen Baylin and others. Scientific Awards: Member, National Academy of Sciences Member, National Academy of Medicine Fellow, AACR Academy Fellow, AAAS Fellow, American Academy of Arts and Sciences Kirk A. Landon Award for Basic Cancer Research (2009) Medal of Honor, American Cancer Society (2011) Outstanding Investigator Grant, NCI Harvey Prize (2024) Advising and Grants: Dr. Jones mentors multiple postdoctoral fellows, graduate students, and research scientists. His lab is supported by major grants, including the VAI-SU2C Epigenetics Dream Team, which has launched 15 clinical trials. He has received sustained funding from the National Cancer Institute and collaborates with institutions worldwide to advance epigenetic therapies. Labs and Teams: He leads the Peter Jones Laboratory at VAI, a multidisciplinary team investigating epigenetic regulation in cancer. The lab includes computational biologists, clinical researchers, and molecular biologists, working on both basic mechanisms and translational applications. The team is part of larger collaborative initiatives such as the VAI-SU2C Epigenetics Dream Team and the International Linked Clinical Trials Program.

Han Joo Leeمشاهده پروفایل

استاد

• Anxiety Disorders
• Psychopathology
• Clinical Psychology
• +۳ مورد دیگر

Han Joo Lee is a Professor and Director of Graduate Studies in the Department of Psychology at the University of Wisconsin-Milwaukee (UWM). He holds appointments in both the College of Letters & Science and the Clinical Psychology program. Lee earned his Ph.D. from the University of Texas at Austin in 2009. His research focuses on adult psychopathology, particularly anxiety disorders (e.g., OCD, social anxiety, PTSD), cognitive-perceptual processing abnormalities, and web-based psychological interventions. He has developed online assessment systems for anxiety disorders and conducted experimental studies on attentional biases and error-monitoring processes in clinical populations. Key research themes include: (1) maladaptive cognitive-perceptual mechanisms underlying anxiety disorders, (2) digital tools for mental health assessment, and (3) behavioral interventions targeting compulsive behaviors. His work integrates experimental, clinical, and neuroscientific approaches to understand symptom maintenance and treatment development. Lee's recent studies explore functional connectivity in skin-picking disorders, predictive factors for OCD treatment outcomes, and dual-hormone stress reactivity in PTSD. He collaborates with institutions like the UWM Psychology Clinic and maintains active grant-funded research projects. No specific awards are listed, but his extensive publication record reflects sustained contributions to clinical psychology. He advises the graduate program at UWM, overseeing training for clinical psychology doctoral students. His lab develops innovative interventions, including computerized response inhibition training for trichotillomania and interpretation-based treatments for thought-action fusion.

Matthew Gauntمشاهده پروفایل

استاد

• Organic Chemistry
• Catalysis
• Chemical Biology
• +۶ مورد دیگر

Matthew Gaunt is the 1702 Yusuf Hamied Professor of Chemistry at the University of Cambridge , specializing in C–H activation , visible-light photocatalysis , and bioconjugation . He leads a research group in Lab 177 , focusing on alkylamine synthesis and chemical biology applications. Gaunt's group has 23 members, including 14 PhD students and 6 postdocs. His research spans catalytic reactivity for organic synthesis, with a focus on metal-catalyzed C–H activation , photoredox strategies , and high-throughput experimentation for rapid reaction development. Key innovations include stereoselective methods for β-lactam synthesis and methionine-targeted protein modification . Scientific Awards & Fellowships: GlaxoWellcome Postdoctoral Fellowship Ramsay Memorial Fellow His group contributes to the SynTech Centre for Doctoral Training , integrating automation and data science into chemical synthesis education. Current students include Joseph Phelps, Marcus Grocott, James Robinson, and Tobias Kraus under his direct supervision.

Anna G Orrمشاهده پروفایل

استادیار

• Neuroscience
• Neurodegenerative Diseases
• Astrocyte Biology
• +۵ مورد دیگر

Anna G Orr serves as Nan and Stephen Swid Assistant Professor of Frontotemporal Dementia Research and Assistant Professor of Neuroscience at Weill Cornell Medical College's Brain and Mind Research Institute since 2016, leading pioneering research on astrocyte biology in dementia pathogenesis. Her educational background includes: Ph.D. from Emory University (2008) B.S. from Allegheny College (2002) Dr. Orr's research program centers on astrocytic-neuronal interactions , mitochondrial signaling , and neuroimmune mechanisms through three interconnected pathways: neuroimmune , oxidative , and G protein-coupled signaling . Her lab investigates how these mechanisms influence neuroinflammation, protein aggregation, synaptic function, and behavioral outcomes in dementia, with parallel therapeutic discovery efforts targeting astrocytic pathways for novel dementia treatments. Analysis of her 15 most recent publications (2025-2010) reveals escalating focus on astrocyte-specific dementia mechanisms , particularly mitochondrial ROS signaling, sex-dimorphic memory effects, TDP-43 pathology interactions with antiviral pathways, and lipid dysregulation in neurodegeneration. Her work consistently bridges molecular discoveries with therapeutic applications, demonstrating increasing NIH funding support for translational approaches. Key scientific recognitions include: NIH K99/R00 Pathway to Independence Award (2017) Leon Levy Fellowship in Neuroscience (2021) Nan and Stephen Swid Endowed Professorship (2021) Outstanding Neuroscience Teaching Award (2021) Dr. Orr actively mentors eight trainees across career stages, including Ph.D. candidates Evelyn Hardin and Constance Zhou, while securing major NIH grants as Principal Investigator for projects like Uncovering Dementia-Related Lipid Alterations in Astrocytes (NIA 2024-2026) and Mitochondrial Complex III Free Radicals in Dementia Pathology (NIA 2020-2026), alongside collaborative awards from the Alzheimer's Association. Her Orr Lab maintains a dual focus on mechanistic astrocyte biology and therapeutic translation, with current projects examining astrocytic TDP-43 dysregulation, mitochondrial complex III signaling, and sex-specific memory mechanisms using advanced in vivo techniques and disease models.

Matti Sällbergمشاهده پروفایل

استاد

• Virology
• Immunology
• Vaccine Development
• +۴ مورد دیگر

Matti Sällberg is a Professor in Biomedical Analysis at Karolinska Institutet's Department of Laboratory Medicine, leading the VIVAC research group focused on vaccines and immunotherapies against viruses and cancer. He earned his DDS and PhD from Karolinska Institutet (1988-1992), followed by postdoctoral research at The Scripps Research Institute (1994-1996). As a leader in infectious disease and hepatology, his research addresses chronic viral hepatitis, cancer prevention, and gene/cell-based therapies (GTMPs/ATMPs). He has directed the Department of Laboratory Medicine (2011-2022) and actively teaches in biomedical laboratory science, dentistry, medicine, and nursing programs. Key research areas include SARS-CoV-2 vaccine development (OPENCORONA consortium), hepatitis B/D/C therapies, and Crimean-Congo hemorrhagic fever vaccines. His work combines basic science with translational efforts at Karolinska's ANA Futura facility. Notable projects include a phase I clinical trial for a broad-acting SARS-CoV vaccine and preclinical testing of hepatitis therapies. Collaborations span academia and industry, with funding from the Swedish Cancer Society, EU, and VINNOVA. He oversees advanced techniques like viral propagation, flow cytometry, and adoptive cell therapy manufacturing. Grants include a 2024 Swedish Cancer Society award for hepatitis-related cancer therapies and a 2022 Swedish Research Council grant for the Doctoral Program in Advanced Therapies. His team maintains an active lab with researchers like Lars Frelin and Gustaf Ahlén. Future work emphasizes expanding vaccine platforms against emerging pathogens and optimizing immuno-therapies for solid tumors.

Tim Denisonمشاهده پروفایل

استاد

• Neural interface technologies
• Algorithm technologies for neurological disease treatment
• Physiologic closed-loop systems
• +۷ مورد دیگر

Professor Tim Denison FREng holds a joint appointment in the Department of Engineering Science and Nuffield Department of Clinical Neurosciences at the University of Oxford, where he serves as the Royal Academy of Engineering Chair in Emerging Technologies and an MRC Investigator. His research focuses on the fundamentals of physiologic closed-loop systems and developing next-generation neural interface technologies for treating chronic neurological diseases. Professor Denison received his A.B. in Physics from The University of Chicago, followed by M.S. and Ph.D. degrees in Electrical Engineering from MIT. He later completed an MBA at The University of Chicago, where he was named a Wallman Scholar. His research spans neural engineering, closed-loop neuromodulation systems, and computational neuroscience, with particular emphasis on deep brain stimulation, neural oscillations, and adaptive neurostimulation techniques. His work integrates engineering principles with clinical neuroscience to develop innovative treatments for neurological disorders. Professor Denison's approach combines computational modeling with experimental validation to optimize brain stimulation parameters for individual patients. Professor Denison has received numerous prestigious awards, including membership in the Bakken Society (2012, Medtronic's highest technical honor), the Wallin leadership award (2014), election to the College of Fellows for the American Institute of Medical and Biological Engineering (2015), and recognition as a Fellow of the Royal Academy of Engineering (FREng). As a former Technical Fellow at Medtronic PLC and Vice President of Research & Core Technology for the Restorative Therapies Group, Professor Denison brings significant industry experience to his academic work. His research group focuses on developing advanced neurostimulation technologies that incorporate chronobiology principles and adaptive algorithms to improve treatment outcomes for neurological conditions.

Ken Pallerمشاهده پروفایل

استاد

• Human memory
• Cognitive neuroscience
• Sleep and cognition
• +۹ مورد دیگر

Ken Paller is Professor of Psychology and Director of the Cognitive Neuroscience Program at Northwestern University, where he holds the James Padilla Chair in Arts & Sciences. He serves as Associate Director of the NIH/NINDS-funded Training Program in the Neuroscience of Human Cognition, dedicated to training future cognitive neuroscientists. Dr. Paller's research focuses on the intricate relationships between brain activity and conscious experience, particularly investigating how memories are formed, stored, and re-experienced. His laboratory has pioneered methods to strategically influence the mind during sleep to improve memory, creativity, and psychological well-being. His work spans multiple domains including memory consolidation during sleep, targeted memory reactivation, lucid dreaming research, and the neural correlates of conscious experience. Notably, he collaborates with Tibetan Monastic Scholars in research on sleep and dreaming, bridging scientific and contemplative traditions. Analysis of his recent publications reveals a strong focus on sleep-dependent memory processes, with particular emphasis on targeted memory reactivation techniques, dream manipulation, and memory modification during sleep. His research demonstrates how sleep can be leveraged to enhance cognitive functions and potentially treat conditions like nightmares in narcolepsy. Dr. Paller received the prestigious Director's Pioneer Award from NIH in 2024 and holds the James Padilla Chair in Arts & Sciences at Northwestern University. His work has garnered significant media attention, featured in outlets including BBC World Service, The World Science Festival, Discover Magazine, NY Times, LA Times, The Economist, NPR Science Friday, and CBC Radio. As Director of the Cognitive Neuroscience Program and Associate Director of the NIH-funded Training Program, Dr. Paller plays a significant role in mentoring the next generation of cognitive neuroscientists. His Cognitive Neuroscience Laboratory (CNL) conducts cutting-edge research at the intersection of sleep science, memory research, and consciousness studies, with implications for both basic science and clinical applications.

Enkelejda Mihoمشاهده پروفایل

استاد

• Digital Life Sciences
• Medical Informatics
• Artificial Intelligence in Healthcare
• +۴ مورد دیگر

Prof. Enkelejda Miho is a Professor of Digital Life Sciences at the School of Life Sciences, FHNW, leading the aiHealthLab. Her work bridges computer science/AI with life sciences, focusing on drug discovery, personalized medicine, and immunology. She holds roles as Team Leader at aiHealthLab and Group Leader at the Swiss Bioinformatics Institute. Research Interests : She applies machine learning to analyze immune repertoires, antibody engineering, and autoimmunity diagnostics. Her lab develops computational tools like the RWD-Cockpit for real-world data analysis and synthetic antibody-antigen models (Absolut!) to advance biotherapeutics. Her work on dengue immunity and monoclonal gammopathies highlights translational applications. Key Projects : The aiHealthLab focuses on AI-driven diagnostics and therapeutics. Her contributions include AI frameworks for antibody specificity prediction, age-related immune repertoire changes, and large-scale network analysis of antibody repertoires. Labs/Teams : Leads aiHealthLab and collaborates with the Swiss Bioinformatics Institute, integrating computational and experimental immunology.

• Cognitive Neuroscience
• Decision Making
• Noradrenergic System
• +۳ مورد دیگر

Professor Sander Nieuwenhuis (Leiden University) specializes in Cognitive Neuroscience of Decision Making through behavioral, EEG, and pharmacological approaches. His work bridges prefrontal cortex function and noradrenergic system mechanisms in human cognition. Studied cognitive psychology (Groningen) and earned PhD (Amsterdam, 2001) International experience: Cambridge University (visiting research), Princeton University (postdoc) Research focuses on noradrenaline's role in attention, decision-making, and cognitive control via: Locus coeruleus-norepinephrine system dynamics Phasic vs. tonic alertness effects Cognitive task performance under neuromodulator deficiency Neuroprotective pathways in Alzheimer's models Recent publications analyze DBH deficiency (Jepma et al., 2011) and attentional blink mechanisms (Nieuwenhuis et al., 2005). His Temporal Attention Lab integrates fMRI, genetics, and computational modeling . Teaching leadership includes: Chair of Research Master Program Committee Coordinator of Scientific Writing courses

Li Minمشاهده پروفایل

دانشیار

• Archaeology
• Chinese Prehistoric and Bronze Age Studies
• Social Memory and State Formation
• +۳ مورد دیگر

Li Min is an Associate Professor at the University of California, Los Angeles (UCLA), affiliated with the Department of Anthropology. His research focuses on Chinese prehistoric and Bronze Age archaeology, emphasizing state formation, social memory, and climatic responses. He also studies maritime archaeology of the Asiatic Trade in the Early Modern Era, using ceramic analysis to trace global trade impacts. Li teaches graduate seminars in archaeology theories and undergraduate courses on Chinese civilizations, collaborating across Anthropology, Asian Languages and Cultures, and the Interdepartmental Program of Archaeology. He co-directs the Wen-Si River Basin archaeological project with Chinese institutions. His 2018 book, Social Memory and State Formation in Early China , is a key contribution to the field. His education includes a Ph.D. from the University of Michigan (2008). Research interests further encompass landscape archaeology, integrating ceramics analysis with remote sensing and historical records. Subfield expertise includes social archaeology, material culture studies, and historical anthropology. Recent publications (2023–2025) concentrate on neuro-oncology imaging innovations, including MRI techniques for glioma characterization, adaptive clinical trials (e.g., GBM AGILE), and biomarker development. These studies highlight advanced applications of AI in medical imaging and molecular targeting therapies for brain tumors. Despite no listed awards, his work on imaging biomarkers and tumor response assessment has advanced clinical neuro-oncology standards. He advises on interdisciplinary collaborations, such as the Wen-Si project, and participates in global clinical trials for glioblastoma therapies.

Sophie Schwartzمشاهده پروفایل

استاد

• Sleep Neuroscience
• Cognitive Neuroscience
• Neuroimaging (fMRI, hd-EEG, MEG)
• +۷ مورد دیگر

Prof. Sophie Schwartz is a leading neuroscientist at the University of Geneva , where she heads the Sleep & Cognition Lab within the Faculty of Medicine . Her research integrates neuroimaging (fMRI, hd-EEG, MEG) , behavioral testing , and computational modeling to unravel the neural mechanisms underlying memory consolidation , emotion processing , and dreaming during sleep, while also developing clinical interventions to enhance sleep in neurological and psychiatric disorders.

Alyson K. Zaltaمشاهده پروفایل

دانشیار

• Trauma
• Posttraumatic Stress Disorder
• Resilience
• +۵ مورد دیگر

Dr. Alyson K. Zalta is an Associate Professor in the Department of Psychological Science at the University of California, Irvine, where she directs the Trauma & Resilience Lab. As a clinical psychologist, her research focuses on alleviating trauma-related mental health burdens through innovative interventions and understanding resilience mechanisms. Education B.A. in Psychology, Harvard University Ph.D. in Clinical Psychology, University of Pennsylvania Clinical Internship, VA Palo Alto Healthcare System Postdoctoral Fellowship, Rush University Medical Center Her research spans trauma, PTSD, resilience, transdiagnostic approaches, and moral injury, with emphasis on high-risk populations including veterans, homeless youth, and urban violence survivors. She integrates neurobiology with behavioral science to identify core trauma pathology mechanisms, exploring novel interventions like light therapy, intensive treatment protocols, and mobile health solutions for vulnerable groups. Her transdiagnostic framework targets universal trauma processes across diagnostic boundaries. Recent publications (2024-2018) reveal consistent focus on moral injury (in nurses, incarcerated individuals, and veterans), circadian-based PTSD treatments, and social determinants of trauma recovery. She employs mixed-methods designs across diverse settings, from pandemic frontline healthcare to homeless youth shelters, prioritizing scalable interventions for real-world impact. Scientific Affiliations Faculty, Interdisciplinary Institute for Salivary Bioscience Research Fellow, Center for the Neurobiology of Learning and Memory Dr. Zalta advises doctoral students in UCI's Psychological Science program (though not accepting new students for Fall 2026 admission) and disseminates findings through podcasts like Psychology Anthology and In the Open. Her Trauma & Resilience Lab actively develops translational research to inform trauma interventions, particularly for underserved populations requiring accessible mental health solutions.

• Epigenetic Pharmacology
• Cancer Therapy
• Drug Discovery
• +۶ مورد دیگر

Noël J-M Raynal is a Professor in the Department of Pharmacology and Physiology at the Université de Montréal and a researcher at the CHU Sainte-Justine Research Center. His expertise lies in epigenetic pharmacology of cancer and drug discovery, particularly using 3D cell culture models to study pediatric and adult cancers. He has held senior research awards from the FRQS and has led multiple projects funded by CIHR, CRSNG, and others. His work focuses on developing novel therapies targeting epigenetic modifications in cancers like neuroblastoma, sarcomas, lung cancer, and triple-negative breast cancer. Education: Ph.D. in Biology (INRS-IAF, 2008), Postdoctoral training at MD Anderson Cancer Center and Temple University. Teaching roles include courses in pharmacology and physiology. Research affiliations: GRUM (University Research Group on Medicine), Azrieli Research Center at CHU Sainte-Justine Awards: Senior FRQS Scholar (2024–2028), Junior FRQS Awards (2016–2024) Supervised 15+ students in M.Sc. and Ph.D. programs, focusing on epigenetic drug discovery and 3D tumor modeling Active in grants: Over 20 projects funded by CIHR, FRQS, and industry partnerships Research highlights include repurposing drugs like disulfiram for neuroblastoma and developing CDK9 inhibitors. His lab innovates in 3D co-culture models to better mimic tumor environments and improve drug screening accuracy.